Foghorn Therapeutics Inc. - Common Stock (FHTX)
4.0000
+0.4700 (13.31%)
NASDAQ · Last Trade: Nov 5th, 6:19 PM EST
Investors and traders are closely monitoring the gap up and gap down stocks in today's session on Tuesday. Let's explore the market movements and identify the stocks with significant gaps.
Via Chartmill · November 4, 2025
Via Benzinga · August 11, 2025
Via Benzinga · April 23, 2025
Via Benzinga · April 1, 2025

Via Benzinga · August 7, 2023

Via Benzinga · February 4, 2025

Via Benzinga · January 30, 2025

Via Benzinga · December 16, 2024

Foghorn Therapeutics shares are trading lower by 20.2% during Monday's session. The company announced it will discontinue independent development of its FHD-286 program.
Via Benzinga · December 16, 2024

Via Benzinga · August 19, 2024

Via Benzinga · August 19, 2024

FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 8, 2024

FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 6, 2024

FHTX stock results show that Foghorn Therapeutics beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 7, 2024

Via Benzinga · February 8, 2024

Via Benzinga · June 8, 2023

Foghorn Therapeutics shares are trading higher by 44.8% Thursday. The company announced that Eli Lilly has chosen FHD-909 for clinical development.
Via Benzinga · February 8, 2024

Gainers Addentax Group Corp. (NASDAQ: ATXG) shares jumped 47.3% to $9.68. Addentax Group is launching automation of artificial intelligence internet operational tools project with top Games-as-a-Service firms.
Via Benzinga · June 30, 2023

Keybanc boosted the price target for Micron Technology, Inc. (NASDAQ: MU) from $70 to $80. Keybanc analyst John Vinh maintained an Overweight rating. Micron shares rose 3.9% to $69.70 in pre-market trading.
Via Benzinga · June 29, 2023

Foghorn Therapeutics Inc (NASDAQ: FHTX) announced the data from the Phase 1 dose escalation safety study of FHD-286 in
Via Benzinga · June 28, 2023

U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping around 40 points on Monday. The Dow traded up 0.05% to 33,827.42 while the NASDAQ fell 0.33% to 12,032.16. The S&P 500, also fell, dropping, 0.01% to 4,132.91.
Via Benzinga · April 24, 2023

Gainers Aclarion, Inc. (NASDAQ: ACON) shares surged 152% to $1.85 amid the publication of durability data for the company's back pain treatment.
Via Benzinga · April 24, 2023
